ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,743Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 1692

$486K Total Retail Price of All Prescriptions

Rank: 259 out of 1692

387 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 6,726 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
CRESTOR 401 351 1 26
AMLODIPINE BESYLATE 398 383 2 3
SIMVASTATIN 296 248 3 1
METOPROLOL TARTRATE 295 266 4 10
OMEPRAZOLE 232 188 5 5
METFORMIN HCL 222 185 6 8
LOSARTAN POTASSIUM 209 178 7 17
SERTRALINE HCL 194 155 8 22
LISINOPRIL 187 174 9 2
METOPROLOL SUCCINATE 185 173 10 18
TORSEMIDE 168 162 11 163
LEVOTHYROXINE SODIUM 165 146 12 4
DIOVAN 153 143 13 42
HYDROCHLOROTHIAZIDE 147 122 14 9
WARFARIN SODIUM 130 109 15 14
TAMSULOSIN HCL 121 81 16 31
FENOFIBRATE 116 96 17 63
SYNTHROID 112 95 18 59
HYDROCODONE-ACETAMINOPHEN 101 88 S3 19 6
LOSARTAN-HYDROCHLOROTHIAZIDE 99 99 20 38
ALENDRONATE SODIUM 94 94 21 36
FUROSEMIDE 83 74 22 7
RANITIDINE HCL 83 68 22 28
PRAVASTATIN SODIUM 80 72 24 12
POTASSIUM CHLORIDE 75 74 25 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 40 26 19
MIRTAZAPINE 68 61 27 53
GABAPENTIN 67 45 28 13
CLOPIDOGREL 64 58 29 43
DILTIAZEM 24HR CD 63 55 30 96
NAMENDA 63 63 30 50
NEXIUM 61 50 32 25
ISOSORBIDE MONONITRATE ER 60 60 33 55
DONEPEZIL HCL 59 59 34 29
FLUTICASONE PROPIONATE 59 52 34 27
ZETIA 56 53 36 68
BYSTOLIC 55 50 37 129
VERAPAMIL ER 55 55 37 90
SPIRIVA 53 45 39 44
PLAVIX 52 45 40 66
GLIMEPIRIDE 50 41 41 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.